Variant report
Variant | esv2494179 |
---|---|
Chromosome Location | chr9:9949836-9951224 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
No data |
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs529045321 | chr9:9949851-9949852 | Weak transcription Flanking Active TSS Enhancers | n/a | n/a | Overlapped CNVs | n/a |
2 | rs74491304 | chr9:9949858-9949859 | Weak transcription Flanking Active TSS Enhancers | n/a | n/a | Overlapped CNVs | n/a |
3 | rs569176790 | chr9:9949868-9949869 | Weak transcription Flanking Active TSS Enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs537811893 | chr9:9949869-9949870 | Weak transcription Flanking Active TSS Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs548988510 | chr9:9949875-9949876 | Weak transcription Flanking Active TSS Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs141570643 | chr9:9949879-9949880 | Weak transcription Flanking Active TSS Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs534327848 | chr9:9949892-9949893 | Weak transcription Flanking Active TSS Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs553929693 | chr9:9949897-9949898 | Weak transcription Flanking Active TSS Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs565687504 | chr9:9949904-9949905 | Weak transcription Flanking Active TSS Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs186561657 | chr9:9949910-9949911 | Weak transcription Flanking Active TSS Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs534866498 | chr9:9949912-9949913 | Weak transcription Flanking Active TSS Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs111606300 | chr9:9949913-9949914 | Weak transcription Flanking Active TSS Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs189780298 | chr9:9949919-9949920 | Weak transcription Flanking Active TSS Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs375202793 | chr9:9949998-9949999 | Weak transcription Flanking Active TSS Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs150914039 | chr9:9950027-9950028 | Enhancers Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
16 | rs560969385 | chr9:9950042-9950043 | Enhancers Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
17 | rs138339871 | chr9:9950043-9950044 | Enhancers Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
18 | rs182398386 | chr9:9950047-9950048 | Enhancers Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
19 | rs569462248 | chr9:9950048-9950049 | Enhancers Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
20 | rs537237442 | chr9:9950050-9950051 | Enhancers Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
21 | rs556906903 | chr9:9950056-9950057 | Enhancers Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
22 | rs149605867 | chr9:9950066-9950067 | Enhancers Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
23 | rs186875660 | chr9:9950088-9950089 | Enhancers Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
24 | rs10816261 | chr9:9950092-9950093 | Enhancers Flanking Active TSS | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
25 | rs556713695 | chr9:9950111-9950112 | Enhancers Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
26 | rs569166568 | chr9:9950112-9950113 | Enhancers Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
27 | rs531681046 | chr9:9950137-9950138 | Enhancers Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
28 | rs548264795 | chr9:9950140-9950141 | Enhancers Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
29 | rs191265379 | chr9:9950145-9950146 | Enhancers Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
30 | rs373189417 | chr9:9950151-9950152 | Enhancers Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
31 | rs117623669 | chr9:9950190-9950191 | Enhancers Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
32 | rs572111998 | chr9:9950196-9950197 | Enhancers Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
33 | rs183015591 | chr9:9950197-9950198 | Enhancers Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
34 | rs570615218 | chr9:9950231-9950232 | Enhancers Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
35 | rs541291496 | chr9:9950254-9950255 | Enhancers Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
36 | rs539603190 | chr9:9950255-9950256 | Enhancers Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
37 | rs77451642 | chr9:9950259-9950260 | Enhancers Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
38 | rs146126413 | chr9:9950262-9950263 | Enhancers Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
39 | rs576659394 | chr9:9950266-9950267 | Enhancers Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
40 | rs139841826 | chr9:9950272-9950273 | Enhancers Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
41 | rs534062387 | chr9:9950276-9950277 | Enhancers Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
42 | rs143321660 | chr9:9950296-9950297 | Enhancers Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
43 | rs80019690 | chr9:9950334-9950335 | Enhancers Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
44 | rs539850998 | chr9:9950372-9950373 | Enhancers Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
45 | rs62536919 | chr9:9950378-9950379 | Enhancers Flanking Active TSS | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
46 | rs146180863 | chr9:9950381-9950382 | Enhancers Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
47 | rs377463310 | chr9:9950398-9950399 | Enhancers Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
48 | rs115568182 | chr9:9950434-9950435 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
49 | rs543890573 | chr9:9950441-9950442 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
50 | rs369798536 | chr9:9950444-9950445 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
abnormal development | 18461090 | CNVD |
Disorders of sex development | 21048976 | CNVD |
Honadal dysgenesis | 21048976 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Lung cancer | 16740712 | CNVD |
Malignant peripheral nerve sheath tumor | 18522746 | CNVD |
Basal cell lymphoma | 17170743 | CNVD |
Follicular lymphoma | 17170743 | CNVD |
Oral squamous cell carcinoma | 17134496 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Breast cancer | 16608533 | CNVD |
Hodgkin''s lymphoma | 18641027 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Breast cancer | 16272173 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Breast cancer | 17133270 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Cervical cancer | 21063398 | CNVD |
Retinoblastoma | 22278416 | CNVD |
Splenic marginal zone lymphoma | 18492102 | CNVD |
Melanoma | 18172304 | CNVD |
Biliary cancer | 19435499 | CNVD |
Gastric cancer | 21586687 | CNVD |
Esophageal squamous carcinoma | 18350619 | CNVD |
Myopathy | 18421352 | CNVD |
Neuroblastoma | 18664255 | CNVD |
Acute lymphoblastic leukemia | 18957548 | CNVD |
Myeloproliferative neoplasm | 17564968 | CNVD |
Malignant meningioma | 17937814 | CNVD |
Glioma | 21971842 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
Astrocytoma | 17387387 | CNVD |
Breast cancer | 17603634 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Oligodendroglial tumors | 17285580 | CNVD |
Cutaneous squamous cell carcinomas | 19131950 | CNVD |
Small bowel adenocarcinoma | 21586687 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Chordoma | 18071362 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Chordoma | 21602918 | CNVD |
Renal cell carcinoma | 18592004 | CNVD |
Developmental delay | 19490664 | CNVD |
Pleomorphic xanthoastrocytoma | 20730472 | CNVD |
microdeletion syndrome | 16199537 | CNVD |
Non-syndromic sensorineural hearing loss | 21987784 | CNVD |
Cancer | 20164919 | CNVD |
Chronic myeloid leukemia | 21384125 | CNVD |
Ovarian cancer | 21720365 | CNVD |
Non-syndromic sensorineural hearing loss | 21030649 | CNVD |
small cell lung cancer | 20016488 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Lung cancer | 18438408 | CNVD |
XY gonadal dysgenesis | 20685758 | CNVD |
Urothelial carcinoma | 21177765 | CNVD |
Oral cancer | 21386901 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Acute lymphoblastic leukemia | 21339820 | CNVD |
Intellectual disability | 22102821 | CNVD |
Breast cancer | 21785460 | CNVD |
Esophageal adenocarcinoma | 19417022 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Breast cancer | 21858162 | CNVD |
Renal cell carcinoma | 21668985 | CNVD |
Myelodysplastic syndrome | 21251322 | CNVD |
Autism | 22495311 | CNVD |
Hepatocellular carcinoma | 18803288 | CNVD |
Breast cancer | 21364760 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Glioblastoma | 19074898 | CNVD |
Malignant melanoma | 19074898 | CNVD |
Prostate cancer | 16573809 | CNVD |
Metanephric adenoma | 20802469 | CNVD |
Ovarian clear cell carcinoma | 21343371 | CNVD |
Cancer | 20164920 | CNVD |
Lung cancer | 20668451 | CNVD |
Schizophrenia | 20838587 | CNVD |
Glioblastoma | 18772890 | CNVD |
Glioblastoma multiforme | 21390271 | CNVD |
Breast cancer | 20668451 | CNVD |
Cancer | 20668451 | CNVD |
Ovarian cancer | 20668451 | CNVD |
Pancreas cancer | 20668451 | CNVD |
Prostate cancer | 20668451 | CNVD |
Autism | 20858261 | CNVD |
Epilepsy | 20858261 | CNVD |
Mental retardation | 20858261 | CNVD |
Developmental delay | 21147756 | CNVD |
small cell lung cancer | 21764851 | CNVD |
Glioblastoma multiforme | 22286061 | CNVD |
Glioma | 17123091 | CNVD |
Lung cancer | 16773561 | CNVD |
Colorectal cancer | 16272173 | CNVD |
Esophageal squamous carcinoma | 18405350 | CNVD |
Gastric cancer | 16891809 | CNVD |
Mental retardation | 17847001 | CNVD |
Cutaneous squamous cell carcinomas | 17420988 | CNVD |
Acute lymphoblastic leukemia | 21390130 | CNVD |
Pilocytic astrocytoma | 18670637 | CNVD |
Acute lymphoblastic leukemia | 17690704 | CNVD |
Acute myeloid leukemia | 21251322 | CNVD |
Lung adenocarcinoma | 17982442 | CNVD |
Breast cancer | 21611746 | CNVD |
Schizophrenia | 23813976 | CNVD |
Bipolar disorder | 19114987 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr9:9949600-9950400 | Enhancers | Pancreatic Islets | Pancreatic Islet |
2 | chr9:9949800-9950000 | Weak transcription | Primary hematopoietic stem cells G-CSF-mobilized Female | -- |
3 | chr9:9949800-9950400 | Flanking Active TSS | Fetal Heart | heart |
4 | chr9:9950000-9950400 | Enhancers | Left Ventricle | heart |
5 | chr9:9950000-9951400 | Enhancers | Primary hematopoietic stem cells G-CSF-mobilized Male | -- |
6 | chr9:9950000-9952400 | Enhancers | Primary hematopoietic stem cells G-CSF-mobilized Female | -- |
7 | chr9:9950400-9950800 | Enhancers | Fetal Heart | heart |
8 | chr9:9950800-9951200 | Flanking Active TSS | Fetal Heart | heart |
9 | chr9:9950800-9952600 | Enhancers | Primary hematopoietic stem cells | blood |
10 | chr9:9951200-9954200 | Enhancers | Fetal Heart | heart |